Royal Bank of Canada’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.61M Sell
71,877
-3,525
-5% -$226K ﹤0.01% 2401
2025
Q1
$4.78M Buy
75,402
+13,767
+22% +$873K ﹤0.01% 2054
2024
Q4
$4.1M Buy
61,635
+4,446
+8% +$296K ﹤0.01% 2167
2024
Q3
$3.99M Sell
57,189
-1,903
-3% -$133K ﹤0.01% 2167
2024
Q2
$3.83M Buy
59,092
+1,718
+3% +$111K ﹤0.01% 2153
2024
Q1
$3.71M Sell
57,374
-36,200
-39% -$2.34M ﹤0.01% 2161
2023
Q4
$6.16M Buy
93,574
+35,343
+61% +$2.33M ﹤0.01% 1789
2023
Q3
$3.32M Buy
58,231
+2,164
+4% +$123K ﹤0.01% 2098
2023
Q2
$3.44M Buy
56,067
+1,449
+3% +$88.8K ﹤0.01% 2094
2023
Q1
$3.43M Sell
54,618
-2,972
-5% -$187K ﹤0.01% 2116
2022
Q4
$3.66M Sell
57,590
-1,646
-3% -$104K ﹤0.01% 2065
2022
Q3
$3.49M Sell
59,236
-9,267
-14% -$546K ﹤0.01% 2048
2022
Q2
$3.96M Sell
68,503
-5,150
-7% -$297K ﹤0.01% 2014
2022
Q1
$4.57M Buy
73,653
+5,942
+9% +$369K ﹤0.01% 2021
2021
Q4
$4.82M Buy
67,711
+10,855
+19% +$773K ﹤0.01% 2050
2021
Q3
$4.26M Sell
56,856
-4,591
-7% -$344K ﹤0.01% 2096
2021
Q2
$4.75M Buy
61,447
+426
+0.7% +$32.9K ﹤0.01% 2070
2021
Q1
$4.5M Sell
61,021
-1,747
-3% -$129K ﹤0.01% 2035
2020
Q4
$4.4M Sell
62,768
-11,082
-15% -$777K ﹤0.01% 1964
2020
Q3
$4.18M Sell
73,850
-1,003
-1% -$56.8K ﹤0.01% 1848
2020
Q2
$4.36M Sell
74,853
-12,131
-14% -$707K ﹤0.01% 1784
2020
Q1
$4.04M Sell
86,984
-28,191
-24% -$1.31M ﹤0.01% 1703
2019
Q4
$6.43M Buy
115,175
+18,950
+20% +$1.06M ﹤0.01% 1661
2019
Q3
$4.56M Buy
96,225
+4,338
+5% +$205K ﹤0.01% 1810
2019
Q2
$4.92M Buy
91,887
+32,525
+55% +$1.74M ﹤0.01% 1760
2019
Q1
$3.28M Sell
59,362
-4,615
-7% -$255K ﹤0.01% 1972
2018
Q4
$3.01M Buy
63,977
+5,849
+10% +$275K ﹤0.01% 1934
2018
Q3
$3.46M Sell
58,128
-7,630
-12% -$454K ﹤0.01% 2030
2018
Q2
$3.6M Sell
65,758
-5,800
-8% -$317K ﹤0.01% 1887
2018
Q1
$3.52M Sell
71,558
-1,996
-3% -$98.2K ﹤0.01% 1868
2017
Q4
$3.47M Buy
73,554
+4,909
+7% +$232K ﹤0.01% 1877
2017
Q3
$3.43M Buy
68,645
+402
+0.6% +$20.1K ﹤0.01% 1843
2017
Q2
$3.12M Buy
68,243
+7,823
+13% +$357K ﹤0.01% 1848
2017
Q1
$2.56M Buy
60,420
+47,599
+371% +$2.01M ﹤0.01% 1945
2016
Q4
$497K Sell
12,821
-9,713
-43% -$377K ﹤0.01% 3072
2016
Q3
$946K Buy
22,534
+9,363
+71% +$393K ﹤0.01% 2540
2016
Q2
$488K Buy
13,171
+1,529
+13% +$56.7K ﹤0.01% 3096
2016
Q1
$445K Sell
11,642
-338
-3% -$12.9K ﹤0.01% 3144
2015
Q4
$605K Sell
11,980
-16,743
-58% -$846K ﹤0.01% 2971
2015
Q3
$1.31M Buy
28,723
+856
+3% +$39.1K ﹤0.01% 2173
2015
Q2
$1.63M Buy
27,867
+6,490
+30% +$379K ﹤0.01% 2129
2015
Q1
$1.18M Buy
21,377
+12,003
+128% +$662K ﹤0.01% 2323
2014
Q4
$471K Sell
9,374
-58,622
-86% -$2.95M ﹤0.01% 3102
2014
Q3
$3.14M Buy
67,996
+3,422
+5% +$158K ﹤0.01% 1633
2014
Q2
$2.82M Sell
64,574
-3,527
-5% -$154K ﹤0.01% 1725
2014
Q1
$2.84M Buy
68,101
+32,294
+90% +$1.34M ﹤0.01% 1685
2013
Q4
$1.33M Buy
35,807
+3,679
+11% +$136K ﹤0.01% 2126
2013
Q3
$1.13M Buy
32,128
+530
+2% +$18.6K ﹤0.01% 2224
2013
Q2
$913K Buy
+31,598
New +$913K ﹤0.01% 2173